Literature DB >> 19793354

Epidemiology, risk factors for and outcome of candidaemia among non-neutropenic patients in a Greek intensive care unit.

Maria Pratikaki1, Evangelia Platsouka, Christina Sotiropoulou, Evangelia Douka, Elizabeth Paramythiotou, Panagiotis Kaltsas, Anastasia Kotanidou, Olga Paniara, Charis Roussos, Christina Routsi.   

Abstract

To determine the epidemiology, risk factors for and outcome of candidaemia in critically ill patients, a matched case-control study was performed in a 25-bed intensive care unit (ICU) from August 2004 to January 2006. Candidaemia occurred in 33 patients; each patient was matched to four controls according to admission illness severity, diagnostic category and length of ICU stay. Candida non-albicans species predominated (67.7%). The presence of acute respiratory distress syndrome (ARDS) was the only independent risk factor for candidaemia development (OR, 2.93; 95% CI 1.09-7.81, P = 0.032). Mortality was 60.6% among patients with candidaemia and 22% among controls (P < 0.001). The presence of candidaemia (OR, 9.37; 95% CI 3.48-25.26, P < 0.001) and the illness severity on admission (acute physiologic and chronic health evaluation II score, OR, 1.17; 95% CI 1.12-1.24, P < 0.001) were independently associated with mortality. Among candidaemic patients, risk factors for mortality were the severity of organ dysfunction (sequential organ failure assessment score, OR, 1.57; 95% CI 1.00-2.46, P = 0.05) and a low serum albumin level (OR, 0.74; 95% CI 0.59-0.94, P = 0.012) both of them occurred on candidaemia onset. We conclude that in critically ill patients matched for illness severity and length of ICU stay, the only independent risk factor for candidaemia was the presence of ARDS. Mortality was independently associated with acquisition of candidaemia and with the illness severity at candidaemia onset.
© 2009 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 19793354     DOI: 10.1111/j.1439-0507.2009.01787.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  11 in total

1.  Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.

Authors:  Maria Siopi; Aikaterini Tarpatzi; Eleni Kalogeropoulou; Sofia Damianidou; Alexandra Vasilakopoulou; Sophia Vourli; Spyros Pournaras; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

2.  An estimate of the burden of serious fungal diseases in Greece.

Authors:  M N Gamaletsou; M Drogari-Apiranthitou; D W Denning; N V Sipsas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-16       Impact factor: 3.267

3.  Risk of invasive candidiasis with prolonged duration of ICU stay: a systematic review and meta-analysis.

Authors:  Zhidan Zhang; Ran Zhu; Zhenggang Luan; Xiaochun Ma
Journal:  BMJ Open       Date:  2020-07-12       Impact factor: 2.692

4.  Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis.

Authors:  Daniel O Thomas-Rüddel; Peter Schlattmann; Mathias Pletz; Oliver Kurzai; Frank Bloos
Journal:  Chest       Date:  2021-10-18       Impact factor: 9.410

Review 5.  Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?

Authors:  Vasiliki Soulountsi; Theodoros Schizodimos; Serafeim Chrysovalantis Kotoulas
Journal:  Infection       Date:  2021-06-16       Impact factor: 3.553

6.  Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project).

Authors:  M T Montagna; G Caggiano; G Lovero; O De Giglio; C Coretti; T Cuna; R Iatta; M Giglio; L Dalfino; F Bruno; F Puntillo
Journal:  Infection       Date:  2013-03-06       Impact factor: 3.553

7.  Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.

Authors:  Gerardo Aguilar; Carlos Delgado; Isabel Corrales; Ana Izquierdo; Estefanía Gracia; Tania Moreno; Esther Romero; Carlos Ferrando; José A Carbonell; Rafael Borrás; David Navarro; F Javier Belda
Journal:  BMC Res Notes       Date:  2015-09-29

8.  Factors predicting prolonged empirical antifungal treatment in critically ill patients.

Authors:  Mohamed Zein; Erika Parmentier-Decrucq; Amer Kalaoun; Olivier Bouton; Frédéric Wallyn; Anne Baranzelli; Dia Elmanser; Boualem Sendid; Saad Nseir
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-03-11       Impact factor: 3.944

9.  Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study.

Authors:  José-Artur Paiva; José Manuel Pereira; Alexis Tabah; Adam Mikstacki; Frederico Bruzzi de Carvalho; Despoina Koulenti; Stéphane Ruckly; Nahit Çakar; Benoit Misset; George Dimopoulos; Massimo Antonelli; Jordi Rello; Xiaochun Ma; Barbara Tamowicz; Jean-François Timsit
Journal:  Crit Care       Date:  2016-03-09       Impact factor: 9.097

10.  Albumin Neutralizes Hydrophobic Toxins and Modulates Candida albicans Pathogenicity.

Authors:  Sophie Austermeier; Marina Pekmezović; Pauline Porschitz; Sejeong Lee; Nessim Kichik; David L Moyes; Jemima Ho; Natalia K Kotowicz; Julian R Naglik; Bernhard Hube; Mark S Gresnigt
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.